Detalles de la búsqueda
1.
Real-world analysis of ruxolitinib in myelofibrosis: interim results focusing on patients who were naïve to JAK inhibitor therapy treated within the JAKoMo non-interventional, phase IV trial.
Ann Hematol
; 102(12): 3383-3399, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37792065
2.
Efficacy and safety of oral panobinostat plus subcutaneous bortezomib and oral dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma (PANORAMA 3): an open-label, randomised, phase 2 study.
Lancet Oncol
; 22(1): 142-154, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33301738
3.
Quality of life and outcome of patients with metastatic pancreatic cancer receiving first-line chemotherapy with nab-paclitaxel and gemcitabine: Real-life results from the prospective QOLIXANE trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer registry.
Int J Cancer
; 148(6): 1478-1488, 2021 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33038277
4.
Ipilimumab or FOLFOX with Nivolumab and Trastuzumab in previously untreated HER2-positive locally advanced or metastatic EsophagoGastric Adenocarcinoma - the randomized phase 2 INTEGA trial (AIO STO 0217).
BMC Cancer
; 20(1): 503, 2020 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32487035
5.
Effect of deferasirox + erythropoietin vs erythropoietin on erythroid response in Low/Int-1-risk MDS patients: Results of the phase II KALLISTO trial.
Eur J Haematol
; 2018 May 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-29777631
6.
Second primary malignancies in treated and untreated patients with chronic lymphocytic leukemia.
Am J Hematol
; 96(12): E457-E460, 2021 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34591989
7.
Nanoliposomal irinotecan and fluorouracil plus leucovorin versus fluorouracil plus leucovorin in patients with cholangiocarcinoma and gallbladder carcinoma previously treated with gemcitabine-based therapies (AIO NALIRICC): a multicentre, open-label, randomised, phase 2 trial.
Lancet Gastroenterol Hepatol
; 2024 Jun 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38870977
8.
Nanoliposomal Irinotecan With Fluorouracil and Leucovorin or Gemcitabine Plus Cisplatin in Advanced Cholangiocarcinoma: A Phase II Study of the AIO Hepatobiliary-YMO Cancer Groups (NIFE-AIO-YMO HEP-0315).
J Clin Oncol
; : JCO2301566, 2024 Jun 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38843469
9.
Cytoreductive treatment in real life: a chart review analysis on 1440 patients with polycythemia vera.
J Cancer Res Clin Oncol
; 148(10): 2693-2705, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34807311
10.
FOLFOX plus panitumumab or FOLFOX alone as additive therapy following R0/1 resection of RAS wild-type colorectal cancer liver metastases - The PARLIM trial (AIO KRK 0314).
Eur J Cancer
; 173: 297-306, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35970102
11.
Efficacy of Ipilimumab vs FOLFOX in Combination With Nivolumab and Trastuzumab in Patients With Previously Untreated ERBB2-Positive Esophagogastric Adenocarcinoma: The AIO INTEGA Randomized Clinical Trial.
JAMA Oncol
; 8(8): 1150-1158, 2022 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35737383
12.
Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer: Long-term Results of the CAO/ARO/AIO-12 Randomized Clinical Trial.
JAMA Oncol
; 8(1): e215445, 2022 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34792531
13.
Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12.
J Clin Oncol
; 37(34): 3212-3222, 2019 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31150315
14.
CONKO-005: Adjuvant Chemotherapy With Gemcitabine Plus Erlotinib Versus Gemcitabine Alone in Patients After R0 Resection of Pancreatic Cancer: A Multicenter Randomized Phase III Trial.
J Clin Oncol
; 35(29): 3330-3337, 2017 Oct 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28817370
15.
Efficacy and Safety of Sequential Use of Everolimus in Patients With Metastatic Renal Cell Carcinoma Previously Treated With Bevacizumab With or Without Interferon Therapy: Results From the European AVATOR Study.
Clin Genitourin Cancer
; 13(3): 231-8, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25456838
Resultados
1 -
15
de 15
1
Próxima >
>>